Skip to main content
SpringerLink
Log in

Adalimumab/certolizumab pegol/secukinumab

Henoch-Schonlein purpura, leucocytoclastic vasculitis and drug ineffectiveness: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Bostan E, et al. Vasculitis during certolizumab pegol and secukinumab treatment: Report of two cases. Dermatologic Therapy 34: e15007, No. 4, Jul-Aug 2021. Available from: URL: http://doi.org/10.1111/dth.15007

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/certolizumab pegol/secukinumab. Reactions Weekly 1872, 20 (2021). https://doi.org/10.1007/s40278-021-01946-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-01946-x

Search

Navigation